Transcatheter Embolization and Occlusion Devices Market Research Report - Forecast till 2030

Transcatheter Embolization and Occlusion Devices Market Research Report by Product (Coiled Devices and Non-Coiled Devices), Indication (Peripheral Vascular Disease, Oncology, Neurology and Urology), End User (Hospitals, Clinics and Ambulatory Surgery Centers) and Region - Forecast till 2030

ID: MRFR/HC/6392-HCR | February 2021 | Region: Global | 90 pages         

Transcatheter Embolization and Occlusion Devices Market

Transcatheter Embolization and Occlusion Devices Market is Expected to Register a Healthy CAGR Over the Forecast Period. The market held a market value of USD 10,378.33 million in 2020 and is projected to grow at a CAGR of 10.60% during the forecast period.

Segmentation

By Product Coiled Devices Non-Coiled Devices
By Indication Peripheral Vascular Disease Oncology Neurology Urology
By End User Hospitals Clinics Ambulatory Surgery Centers

Key Players

  • Medtronic plc
  • Stryker Corporation
  • Terumo Corporation
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Pfizer Inc.
  • Cardinal Health
  • DePuy Synthes
  • Cook Medical
  • Sirtex Medical Limited

Drivers

  • Rising preference for minimally invasive surgeries (MISs)
Speak to Analyst Request a Free Sample

Transcatheter Embolization and Occlusion Devices Market Scenario


Transcatheter Embolization and Occlusion Devices Market is Expected to Register a Healthy CAGR Over the Forecast Period. The market held a market value of USD 10,378.33 million in 2020 and is projected to grow at a CAGR of 10.60% during the forecast period. Transcatheter embolization and occlusion (TEO) is a minimally invasive (MI) procedure performed in interventional radiology wherein a synthetic embolus is placed or inserted through a fine catheter in the blood vessel to obstruct the blood flow towards tumor or specific area of the body. Coils are permanent embolic agents which come in a variety of shapes and sizes and are coated with chemotherapeutic drugs that block the blood supply as well as induce cytotoxicity to attack the tumor. Particulate agents such as polyvinyl alcohol (PVA) and gelatin-impregnated acrylic polymer spheres are suspended in liquid and injected into the bloodstream to block small blood vessels. This procedure is used to prevent abnormal bleeding, eliminate abnormal connections between arteries and veins, and to treat the aneurysm.

Few of the major factors driving the market growth are growing burden of targeted diseases, technological advances in the devices with enhanced efficiency, changing shift from clipping to coiling, rising preference for minimally invasive surgeries (MISs), and increasing adoption of TEO devices. Venous malformations are the most common of all vascular anomalies. For instance, according to the International Society for Auricular Reconstruction (ISAR), in 2017, the overall incidence of venous malformations was reported in 1% to 4% of the population, without any predilection in the sex. On the flip side, the high cost of products and the presence of stringent regulatory framework for product commercialization are anticipated to impede the market growth during the forecast period.


Segmentation


The transcatheter embolization and occlusion devices market has been segmented into product, indication, end user, and region.


By product, the market has been segmented into coiled devices and non-coiled devices. The coiled devices segment has been further categorized into pushable coils and detachable coils. The non-coiled devices segment has been additionally divided into flow diverting devices, embolization particles, liquid embolic, other embolization and occlusion devices, and accessories.


 The coiled devices segment is expected to dominate the market due to the availability of wide-range of coils in various shapes and sizes that enables suitable product selection for different cases, making coiling a preferred treatment for embolization. The non-coiled devices segment is likely to witness lucrative market growth during the forecast period due to increasing demand for flow diverting devices, embolization particles, liquid embolic, and accessories.


On the basis of indication, the market has been divided into peripheral vascular disease, oncology, neurology, urology, and others.


Based on end user, the market has been categorized into hospitals and clinics, ambulatory surgery centers (ASCs), and others.


The transcatheter embolization and occlusion devices market has been segmented by region into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The transcatheter embolization and occlusion devices market in the Americas has further been segmented into North America and Latin America, with the North American market divided into the US and Canada.


The European transcatheter embolization and occlusion devices market has been segmented into Western Europe and Eastern Europe. Western Europe, transcatheter embolization and occlusion devices market, has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.


The transcatheter embolization and occlusion devices market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The transcatheter embolization and occlusion devices market in the Middle East & Africa has been segmented into the Middle East and Africa.


Key Players



  • Medtronic plc

  • Stryker Corporation

  • Terumo Corporation

  • Abbott Laboratories

  • Boston Scientific Corporation

  • Pfizer Inc.

  • Cardinal Health

  • DePuy Synthes

  • Cook Medical

  • Sirtex Medical Limited


Regional Market Summary


Transcatheter Embolization and Occlusion Devices Market Share (%), by Region, 2018  Transcatheter Embolization and Occlusion Devices Market_Image


Source: White Papers, Company Presentations, Annual Reports, and MRFR Analysis


Geographically, the Americas held substantial market share in 2018 attributed to the presence of key market participants, sophisticated healthcare infrastructure and reimbursement coverage, and the incidence of target diseases (fibroid tumor and arteriovenous malformations) in the US and Canada. For instance, as per the data provided by the Association of Neurological Surgeons (AANS), in 2017, the prevalence of arteriovenous malfunctions (AVM) was 18 people per 100,000 population in the US.


Europe would be the second largest value contributor in the global market due to robust growth in radioembolization spheres, drug-eluting beads, and flow-diverting devices. Improved detection and screening have treated hepatocellular carcinoma and metastatic liver cancer population across the country.


Asia-Pacific is expected to represent profitable market growth from 2018 to 2024 owing to the booming medical tourism industry in emerging economies, namely, China, India, Australia, and Malaysia, growing awareness about TEO procedure, and increasing adoption of transcatheter embolization and occlusion procedures. For instance, the International Medical Travel Journal (IMTJ) reported that Indian hospitals served 460,000 international patients from 2015 to 2016 for various surgical procedures.


The transcatheter embolization and occlusion devices market in the Middle East & Africa would witness the modest market growth rate from 2018 to 2024. The Middle East would spearhead the market.

Transcatheter Embolization and Occlusion Devices Market, by Product



  • Coiled Devices

    • Pushable Coils

    • Detachable Coils



  • Non-Coiled Devices

    • Flow-Diverting Devices

    • Embolization Particles

    • Liquid Embolic

    • Other Embolization and Occlusion Devices

    • Accessories




Transcatheter Embolization and Occlusion Devices Market, by Indication



  • Peripheral Vascular Disease

  • Oncology

  • Neurology

  • Urology

  • Others


Transcatheter Embolization and Occlusion Devices Market, by End User



  • Hospitals and Clinics

  • Ambulatory Surgery Centers (ASCs)

  • Others


Transcatheter Embolization and Occlusion Devices Market, by Region



  • Americas

    • North America

      • US

      • Canada



    • Latin America



  • Europe

    • Western Europe

      • Germany

      • France

      • Italy

      • Spain

      • UK

      • Rest of Western Europe



    • Eastern Europe



  • Asia-Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific



  • Middle East & Africa

    • Middle East

    • Africa




Intended Audience



  • Transcatheter embolization and occlusion devices providers

  • Venture capitalists

  • Medical devices companies

  • Research and academic institutes

  • Healthcare facilities

  • Association and government bodies

  • Market research and consulting service providers

  • Corporate entities



Report Scope:
Report Attribute/Metric Details
  Market Size   2030: USD 10,378.33 Million
  CAGR   10.60% (2020-2030)
  Base Year   2019
  Forecast Period   2020-2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Product, Indication, End user
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   bbott Laboratories, Medtronic plc, Boston Scientific Corporation, Stryker Corporation, Terumo Corporation, Pfizer Inc., DePuy Synthes, Cardinal Health, Cook Medical, Sirtex Medical Limited, and Merit Medical Systems.
  Key Market Opportunities   New product launches and R&D Amongst major key Players
  Key Market Drivers

  • Growing burden of targeted diseases
  • Technological advances in the devices with enhanced efficiency
  • Changing shift from clipping to coiling
  • Rising preference for minimally invasive surgeries (MISs)
  • Increasing adoption of TEO devices


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :

    The transcatheter embolization and occlusion devices market is projected to grow at a 10.60% CAGR between 2020-2030.

    The Americas is expected to lead the transcatheter embolization and occlusion devices market.

    Different end users of the transcatheter embolization and occlusion devices market include ambulatory surgery centers, hospitals and clinics, and others.

    Key competitors in the transcatheter embolization and occlusion devices market include Merit Medical Systems, Sirtex Medical Limited, Cook Medical, Cardinal Health, DePuy Synthes, Terumo Corporation, Pfizer Inc., Stryker Corporation, Boston Scientific Corporation, Medtronic plc, and Abbott Laboratories.

    Strict regulatory framework and costlier products may limit market growth.